SCHEMBL17490366

SCHEMBL17490366

C[C@@H]1CCC[C@@](C)(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17490365 1.00
SCHEMBL10089211 1.00
SCHEMBL17490375 1.00
SCHEMBL10089206 1.00
SCHEMBL2343668 1.00
SCHEMBL24267449 1.00
SCHEMBL6822238 0.84
SCHEMBL15214411 0.84
SCHEMBL15214415 0.84
SCHEMBL16365741 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174877-B1 INDOLIZINE DERIVATIVES WHICH ARE APPLICABLE TO NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2022-06-29 EP disclosed
WO-2020081508-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2020-04-23 WO disclosed
US-20170079965-A1 NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2017-03-23 US disclosed
US-9546166-B2 Indolizine derivatives and their use in neurodegenerative diseases MERCK PATENT GMBH (DE) 2017-01-17 US disclosed
US-20160031879-A1 NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2016-02-04 US disclosed
WO-2016019228-A1 INDOLIZINE DERIVATIVES WHICH ARE APPLICABLE TO NEURODEGENERATIVE DISEASES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed